Kinnate Biopharma Inc logo

Kinnate Biopharma Inc Share Price (NASDAQ: KNTE)

▲

-2.65

(-100%)

Live

Last updated on

Bell Icon

The stock has been delisted from the stock exchange on 2 Apr 2024

Check the interactive Kinnate Biopharma Inc Stock chart to analyse performance

Kinnate Biopharma Inc Key Stats

Check Kinnate Biopharma Inc key stats like market cap, P/E ratio, EPS, Dividend Yield, and more.

Previous Close
$2.65
Open
$2.64
Market Capitalization
$124.5M
Today's Volume
$2.8M
Revenue TTM
$0.0
EBITDA
$-131.8M
Earnings Per Share (EPS)
$-2.78
Profit Margin
0.0%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-55.8%

Global Institutional Holdings in Kinnate Biopharma Inc

  • Name

    Holdings %

  • Foresite Capital Management IV, LLC

    20.51%

  • Orbimed Advisors, LLC

    16.98%

  • Foresite Capital Management V, LLC

    7.48%

  • Vida Ventures Advisors, LLC

    4.68%

  • Viking Global Investors LP

    3.86%

  • Citadel Advisors Llc

    2.25%

Analyst Recommendation on Kinnate Biopharma Inc Stock

Rating
Trend

Buy

    61%Buy

    38%Hold

    0%Sell

Based on 13 Wall street analysts offering stock ratings for Kinnate Biopharma Inc(by analysts ranked 0 to 5 stars)

About Kinnate Biopharma Inc

Kinnate Biopharma Inc., a clinical-stage oncology company, focuses on the discovery and development of small molecule kinase inhibitors to treat genomically defined cancers in the United States. The company develops KIN-2787, a rapidly accelerated fibrosarcoma inhibitor for the treatment of patients with lung cancer, melanoma, and other solid tumors; KIN-3248 small-molecule kinase inhibitors that target cancer-associated alterations in fibroblast growth factor receptors FGFR2 and FGFR3 genes; and small molecule research programs, including Cyclin-Dependent Kinase 12(CDK12) inhibitor in its KIN004 program. The company was incorporated in 2018 and is headquartered in San Francisco, California. Kinnate Biopharma Inc. is a former subsidiary of Fount Therapeutics, LLC.
Organization
Kinnate Biopharma Inc
Employees
84
CEO
Mr. Nima Farzan M.B.A.
Industry
Miscellaneous

Important FAQs about investing in KNTE Stock from India :

What is Kinnate Biopharma Inc share price today?

Kinnate Biopharma Inc share price today is as on . Kinnate Biopharma Inc share today touched a day high of {{1_rba_end}} and a low of {{1_rba_st}}.

What is the 52 week high and 52 week low for Kinnate Biopharma Inc share?

Kinnate Biopharma Inc share touched a 52 week high of {{rba_end}} and a 52 week low of {{rba_st}}. Kinnate Biopharma Inc stock price today i.e. is trending at , lower by 100% versus the 52 week high.

How to invest in Kinnate Biopharma Inc Stock (KNTE) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Kinnate Biopharma Inc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Kinnate Biopharma Inc Shares .

What is the minimum amount required to buy Kinnate Biopharma Inc Stock (KNTE) from India?

Indian investors can start investing in Kinnate Biopharma Inc (KNTE) shares with as little as ₹88.097 or $1 (as of September 18, 2025) using the INDmoney app.
For example: If you want to invest $10 or ₹880.97 in Kinnate Biopharma Inc stock (as per the Rupee-Dollar exchange rate as on September 18, 2025). Learn more about fractional shares .

What are the returns that Kinnate Biopharma Inc has given to Indian investors in the last 5 years?

Kinnate Biopharma Inc stock has given 0.0% share price returns and 19.79% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?